XII Medical

XII Medical is a private, clinical-stage medical device and digital health company targeting the large and underserved Obstructive Sleep Apnea (OSA) market. The company is developing a best-in-class, smart wearable neuromodulation therapy designed to be a simpler and more accessible alternative to current standard treatments like CPAP. Leveraging integrated hardware and software, XII Medical seeks to address low patient adherence rates and improve long-term disease management. Its focus on a streamlined, patient-centric solution positions it in a high-growth segment of the digital therapeutics and neurostimulation landscape.

Integrated smart wearable neuromodulation device paired with a digital health platform for remote monitoring and therapy optimization.

XII Medical competes in the OSA therapy market against dominant CPAP manufacturers (ResMed, Philips), the leading implantable hypoglossal nerve stimulator company (Inspire Medical Systems), and a growing field of startups exploring alternative devices (e.g., oral appliances, positional therapy, new neurostimulation approaches). Its wearable, non-implantable approach seeks to carve out a middle ground between these segments.